ADC Therapeutics SA (ADCT) Current Reports & Earnings Releases
Upcoming
- 2026-11-09 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-13 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-07-02 | 8-K | Officer / Director Changes | SEC |
| 2026-06-24 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2026-06-03 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2026-06-02 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2026-05-04 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-03-10 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-02-23 | 8-K | Material Agreement, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2026-01-12 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-01-08 | 8-K | Results of Operations, Reg FD Disclosure | SEC |
| 2025-12-05 | 8-K | Other Events | SEC |
| 2025-11-10 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-10-14 | 8-K | Material Agreement, Results of Operations, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2025-09-30 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-08-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-06-12 | 8-K | Material Agreement, Item 2.05, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2025-06-05 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2025-05-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-03-27 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-01-13 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-11-13 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-11-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-08-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-06-14 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-05-14 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-05-08 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-05-06 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-04-09 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-03-13 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-03-05 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-02-29 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2024-01-24 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-01-19 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-01-04 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-01-04 | 8-K | Other Events | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.